Nothing to See Here, Move Along
The Supreme Court’s recent unanimous decision on FDA’s drug-approval authority is utterly unremarkable.
The Supreme Court’s 2024-2025 Regulatory Term
Scholars and practitioners examine the Court’s most important regulatory decisions of this past term.
Toward a More Accessible and Accountable Administrative State
ACUS recommends best practices for nonlawyer representation, AI tools, and public participation in rulemaking.
President Trump’s First 100 Days of Deregulation
Scholars examine the pace and potential impact of President Trump’s first 100 days.
Week in Review
The Supreme Court allows Department of Education layoffs, a federal court upholds a mifepristone ban, and more…
Antitrust and Algorithmic Pricing
Scholars consider the antitrust implications of advances in AI-driven algorithmic pricing.
Week in Review
President Trump’s megalaw cuts health care funding, the Supreme Court allows President Trump’s layoffs, and more…
The Dangers of AI in the Courtroom
Scholars examine the dangers of difficult-to-understand AI in criminal investigations and cases.
Regulating Artificial Intelligence in the Shadow of Mental Health
Scholar argues for an approach to regulating artificial intelligence centered on mental health.
The Pregnant Workers Fairness Act After Dobbs
Recent legislation could protect pregnant workers who choose to have an abortion.